Pan-tumor(NSCLC, GYN Cancers, BTC and UC) Clinical Trials in Chengdu

A Multicenter, Non-interventional, Descriptive Study to Assess Assay Concordance of HER2 IHC Testing in Chinese Pan-tumor Patients